 Aneta Gandjeva
Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 8 | 2023 | 1771 | 0.640 |
Why?
| | Histological Techniques | 1 | 2018 | 42 | 0.600 |
Why?
| | Lung | 8 | 2020 | 3588 | 0.560 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2023 | 244 | 0.340 |
Why?
| | Hypoxia | 5 | 2023 | 950 | 0.250 |
Why?
| | Pulmonary Artery | 5 | 2023 | 1025 | 0.250 |
Why?
| | Vascular Remodeling | 3 | 2022 | 150 | 0.230 |
Why?
| | Sirtuin 3 | 1 | 2023 | 55 | 0.220 |
Why?
| | Pulmonary Emphysema | 2 | 2020 | 318 | 0.210 |
Why?
| | Pneumonia | 2 | 2020 | 575 | 0.210 |
Why?
| | Fibroblasts | 3 | 2023 | 839 | 0.210 |
Why?
| | Acute Lung Injury | 2 | 2017 | 268 | 0.200 |
Why?
| | Scleroderma, Systemic | 1 | 2022 | 94 | 0.200 |
Why?
| | Endothelial Cells | 3 | 2023 | 698 | 0.180 |
Why?
| | Platelet Activation | 1 | 2020 | 65 | 0.180 |
Why?
| | Disease Models, Animal | 9 | 2022 | 3648 | 0.180 |
Why?
| | Laser Capture Microdissection | 2 | 2018 | 25 | 0.180 |
Why?
| | Transcription Factors | 3 | 2014 | 1557 | 0.180 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 219 | 0.160 |
Why?
| | Pulmonary Alveoli | 3 | 2017 | 373 | 0.160 |
Why?
| | Mice, Knockout | 8 | 2020 | 2648 | 0.160 |
Why?
| | Blood Platelets | 1 | 2020 | 328 | 0.150 |
Why?
| | Complement Activation | 1 | 2020 | 343 | 0.140 |
Why?
| | DNA-Binding Proteins | 2 | 2014 | 1340 | 0.140 |
Why?
| | Alveolar Epithelial Cells | 1 | 2017 | 101 | 0.140 |
Why?
| | MicroRNAs | 1 | 2022 | 627 | 0.140 |
Why?
| | Mice | 12 | 2022 | 15311 | 0.130 |
Why?
| | Schistosomiasis mansoni | 1 | 2015 | 24 | 0.130 |
Why?
| | Immunoglobulin G | 1 | 2020 | 786 | 0.130 |
Why?
| | Animals | 15 | 2023 | 32741 | 0.130 |
Why?
| | Interleukin-13 | 1 | 2015 | 134 | 0.130 |
Why?
| | Interleukin-4 | 1 | 2015 | 216 | 0.120 |
Why?
| | Rats | 5 | 2022 | 5172 | 0.120 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2014 | 366 | 0.120 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1657 | 0.110 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 148 | 0.110 |
Why?
| | Pulmonary Veins | 1 | 2013 | 84 | 0.110 |
Why?
| | Glycocalyx | 1 | 2012 | 23 | 0.100 |
Why?
| | Ceramides | 1 | 2012 | 96 | 0.100 |
Why?
| | Endotoxemia | 1 | 2012 | 85 | 0.100 |
Why?
| | Nerve Growth Factors | 1 | 2011 | 73 | 0.100 |
Why?
| | Heart Diseases | 1 | 2013 | 336 | 0.090 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2020 | 142 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 286 | 0.080 |
Why?
| | Macrophages | 1 | 2015 | 1297 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2023 | 350 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 399 | 0.070 |
Why?
| | Neutrophils | 1 | 2012 | 1081 | 0.070 |
Why?
| | Endothelium, Vascular | 1 | 2013 | 860 | 0.070 |
Why?
| | Inflammation | 4 | 2020 | 2515 | 0.070 |
Why?
| | Smoking | 2 | 2012 | 1457 | 0.070 |
Why?
| | Humans | 13 | 2023 | 117098 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2011 | 690 | 0.060 |
Why?
| | Signal Transduction | 1 | 2017 | 4606 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2015 | 4841 | 0.060 |
Why?
| | NAD | 1 | 2023 | 66 | 0.060 |
Why?
| | Apoptosis | 1 | 2012 | 2433 | 0.060 |
Why?
| | Monocrotaline | 1 | 2022 | 35 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 2 | 2014 | 400 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 331 | 0.050 |
Why?
| | Imatinib Mesylate | 1 | 2022 | 64 | 0.050 |
Why?
| | Immunoenzyme Techniques | 2 | 2013 | 194 | 0.050 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2022 | 191 | 0.050 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 223 | 0.050 |
Why?
| | Platelet Factor 4 | 1 | 2020 | 21 | 0.050 |
Why?
| | Deferoxamine | 1 | 2020 | 16 | 0.050 |
Why?
| | Chemokine CCL5 | 1 | 2020 | 46 | 0.050 |
Why?
| | Iron Chelating Agents | 1 | 2020 | 16 | 0.050 |
Why?
| | Cattle | 1 | 2023 | 957 | 0.050 |
Why?
| | Hepatocyte Growth Factor | 1 | 2020 | 33 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2023 | 3956 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2014 | 391 | 0.050 |
Why?
| | Pericytes | 1 | 2020 | 24 | 0.050 |
Why?
| | Phenotype | 2 | 2023 | 2892 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 965 | 0.040 |
Why?
| | Microvessels | 1 | 2020 | 69 | 0.040 |
Why?
| | Complement C5 | 1 | 2020 | 74 | 0.040 |
Why?
| | Blotting, Western | 2 | 2013 | 1172 | 0.040 |
Why?
| | Pyrroles | 1 | 2020 | 186 | 0.040 |
Why?
| | Immunoglobulins | 1 | 2020 | 149 | 0.040 |
Why?
| | Fatty Acids | 1 | 2022 | 398 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2012 | 793 | 0.040 |
Why?
| | Smoke | 1 | 2020 | 135 | 0.040 |
Why?
| | Complement Factor B | 1 | 2020 | 100 | 0.040 |
Why?
| | Thrombocytopenia | 1 | 2020 | 179 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2020 | 215 | 0.040 |
Why?
| | Complement Pathway, Alternative | 1 | 2020 | 113 | 0.040 |
Why?
| | Complement C3 | 1 | 2020 | 191 | 0.040 |
Why?
| | Pulmonary Circulation | 1 | 2020 | 406 | 0.040 |
Why?
| | Indoles | 1 | 2020 | 311 | 0.040 |
Why?
| | Cell Proliferation | 2 | 2017 | 2236 | 0.040 |
Why?
| | Mitochondria | 1 | 2023 | 775 | 0.040 |
Why?
| | Chemokine CXCL12 | 1 | 2017 | 77 | 0.040 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 78 | 0.040 |
Why?
| | Permeability | 1 | 2017 | 153 | 0.040 |
Why?
| | Protein Kinase Inhibitors | 1 | 2022 | 803 | 0.040 |
Why?
| | Interleukin-4 Receptor alpha Subunit | 1 | 2015 | 8 | 0.030 |
Why?
| | STAT6 Transcription Factor | 1 | 2015 | 22 | 0.030 |
Why?
| | Smad3 Protein | 1 | 2015 | 45 | 0.030 |
Why?
| | Smad2 Protein | 1 | 2015 | 39 | 0.030 |
Why?
| | Schistosoma mansoni | 1 | 2015 | 39 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 1853 | 0.030 |
Why?
| | Th17 Cells | 1 | 2015 | 57 | 0.030 |
Why?
| | Wound Healing | 1 | 2017 | 269 | 0.030 |
Why?
| | Th1 Cells | 1 | 2015 | 131 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2013 | 2632 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 171 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 244 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2017 | 512 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 103 | 0.030 |
Why?
| | Receptors, Urokinase Plasminogen Activator | 1 | 2013 | 14 | 0.030 |
Why?
| | Female | 5 | 2022 | 60672 | 0.030 |
Why?
| | Endotoxins | 1 | 2014 | 208 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 456 | 0.030 |
Why?
| | Lung Compliance | 1 | 2012 | 48 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 75 | 0.030 |
Why?
| | Male | 5 | 2020 | 56700 | 0.030 |
Why?
| | Heparitin Sulfate | 1 | 2012 | 42 | 0.030 |
Why?
| | Glucuronidase | 1 | 2012 | 44 | 0.030 |
Why?
| | Intestinal Perforation | 1 | 2012 | 37 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 76 | 0.030 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2012 | 102 | 0.030 |
Why?
| | Airway Remodeling | 1 | 2012 | 57 | 0.030 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 1114 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2012 | 203 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3391 | 0.030 |
Why?
| | Endothelium | 1 | 2012 | 113 | 0.030 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 49 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2012 | 152 | 0.030 |
Why?
| | Netrin-1 | 1 | 2011 | 11 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2670 | 0.020 |
Why?
| | Epoprostenol | 1 | 2012 | 132 | 0.020 |
Why?
| | Emphysema | 1 | 2012 | 123 | 0.020 |
Why?
| | Sex Distribution | 1 | 2012 | 331 | 0.020 |
Why?
| | Phosphorylation | 1 | 2015 | 1590 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2012 | 428 | 0.020 |
Why?
| | Kidney Function Tests | 1 | 2011 | 160 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2012 | 286 | 0.020 |
Why?
| | Creatinine | 1 | 2011 | 481 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1239 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2014 | 1993 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 982 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 825 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 798 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2012 | 286 | 0.020 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 434 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2321 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2011 | 686 | 0.020 |
Why?
| | Heart-Assist Devices | 1 | 2013 | 486 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1136 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2012 | 940 | 0.020 |
Why?
| | Homeostasis | 1 | 2010 | 588 | 0.020 |
Why?
| | NF-kappa B | 1 | 2010 | 639 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3099 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2012 | 1148 | 0.020 |
Why?
| | Aged | 2 | 2013 | 19373 | 0.020 |
Why?
| | Kidney | 1 | 2011 | 1344 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2408 | 0.010 |
Why?
| | Middle Aged | 2 | 2013 | 27189 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 5052 | 0.010 |
Why?
| | Prospective Studies | 1 | 2013 | 6391 | 0.010 |
Why?
| | Adult | 2 | 2013 | 31014 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 10680 | 0.010 |
Why?
| | Adolescent | 1 | 2013 | 18219 | 0.010 |
Why?
| | Child | 1 | 2013 | 18881 | 0.010 |
Why?
|
|
Gandjeva's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|